BIMSB News

Spatially resolved transcriptomics are changing the way we understand complex tissues, as Nature Methods wrote when it crowned the technology “Method of the Year 2020.” A SCOG virtual workshop has now provided an overview of the latest findings and developments in this exciting field.

Leif S. Ludwig has received the Hector Research Career Development Award for his research into the DNA of cellular power plants, the mitochondria. The award supports particularly talented young scientists as they embark on the first steps of their research careers.

A year ago, BIH, MDC and Charité launched the joint research focus "Single Cell Approaches for Personalised Medicine". Its aim is to use innovative single cell technologies to answer clinical questions. This aspiration will be put into practice by four new junior research groups, which have now started.

In the lab, Jan Philipp Junker is working on cell lineages. He is trying to understand how zebrafish repair their own hearts. In his spare time, he likes to read a lot. For our series "What are you reading right now?", the systems biologist takes us to the East Coast of the USA, to Boston. Not to the MIT, but to a milieu of tennis players and drug addicts.

On January 1, 2021, the Berlin Institute of Health (BIH) has become the translational research unit of Charité – Universitätsmedizin Berlin and will then form – alongside the hospital and the medical faculty – Charité’s third pillar.

Neuroscience is one of Berlin’s strongest fields of research. The Berlin Brains lecture series at Urania shows the breadth and depth of this research expertise in the capital city – this year under the theme “Junior Meets Senior.” The MDC’s Thomas Willnow and Anna Löwa are kicking off the series.

What side effects should I expect from the vaccines against the new SARS-CoV-2 coronavirus? Have they been developed too fast? To support a factual debate, our experts from the fields of immunology and RNA biology answered frequently asked questions.

In December 2020, biophysicist Melissa Birol joined the MDC as a new junior group leader to investigate the behavior and function of disordered proteins in brain cells.

A new textbook “Computational Genomics with R” written by MDC/BIMSB's Altuna Akalin will be published this month. The book aims to assist to a wide range of readers, providing both an introduction to genomics and step-by-step instructions to help biologists analyze their own datasets.

The 13th Berlin Summer Meeting “Rising from the Ashes – Regeneration at the Single Cell Level” will take place as a Christmas Special on Dec. 10-11, 2020. The free, virtual conference will feature talks about regeneration research in animals and organoids.

By analyzing the gene expression of single cells, algorithms are able to not only reconstruct their original location in the tissue, but also to determine details about their function. Teams led by Kai Schmidt-Ott and Nikolaus Rajewsky have published their findings in JASN, using the kidney as an example.

On November 7, 2020, the Berlin Institute of Health (BIH) and the Tagesspiegel are hosting the fifth edition of the Future Medicine Science Match. This year’s focus is “Artificial Intelligence in Translational Medicine.” MDC researcher Roland Schwarz is chair of the session on AI in basic research.

The Berlin Institute of Medical Systems Biology (BIMSB) will host an international, virtual workshop about condensates and phase transitions on Nov. 27, 2020.

A large grant under the NIH’s 4D Nucleome Program supports BIMSB/MDC scientist Ana Pombo’s work as a member of a multi-team consortium led by UC San Diego in the U.S. The team will investigate how DNA organizes inside cell nuclei and functions in space and time.

Female moles not only have ovarian, but also testicular tissue that produces male sex hormones – which lets them diverge from the categorization into two sexes. A team led by Berlin researchers Stefan Mundlos and Darío Lupiáñez describes in Science which genetic modifications contribute to this singular development.

When virologists become reality TV stars, biologists dream of life without illness, researchers debate organoids vs. animal testing with the general public, and biomedical scientists discuss the possibilities of AI, it can only be Berlin Science Week.

Berlin will become one of four new National Center for Tumor Diseases (NCT) locations in addition to Heidelberg and Dresden.

Berlin has a long tradition as a medical metropolis and also the potential to become an international hub for the life sciences, comparable to Boston. On September 28, researchers from both cities will discuss this issue with the Governing Mayor of Berlin, Michael Müller

The LifeTime initiative has published a perspective in Nature and the LifeTime Strategic Research Agenda, presenting a roadmap of how to leverage the latest scientific breakthroughs and technologies over the next decade.

A new algorithmic approach - developed by a team of researchers led by the BIMSB/MDC (Roland Schwarz lab), The Francis Crick Institute and the University College London - reveals individual tumors continue to evolve and remodel their genomes, and this occurs across a broad range of tumor types. Identifying changes that benefit tumors and help them metastasize could help with future treatments. Results are published in Nature.

DC researchers Mina Gouti and Nikolaus Rajewsky received a $150,000 pilot project grant from the Chan Zuckerberg Initiative’s Neurodegeneration Challenge Network to investigate a defining feature of amyotrophic lateral sclerosis (ALS).

A severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a continuous loop of activation and inhibition. This is reported in Cell by experts of the nationwide deCOI research network, including members of BIMSB's Landthaler lab.

Kerstin Radomski, a Bundestag member for the CDU and an expert on budgetary issues, visited the MDC/BIMSB in early August. She wanted to learn about research into diseases such as cardiovascular disorders, cancer and Covid-19, as well as about the opportunities that data science offers and the clinical application of scientific discoveries.

The group of Altuna Akalin has developed a new tool that makes it easier to maximize the power of deep learning for studying genomics. They describe the new approach, Janggu, in the journal Nature Communications

Dr. Laleh Haghverdi joins the BIMSB/MDC on July 1st to lead a new group: Computational Methodologies and Omic Analytics. She brings her expertise in finding mathematical approaches to improve single-cell, multi-omics data integration and analysis.

DC researcher Jan Philipp Junker and his collaborator Maria Colomé-Tatché at Helmholtz Center Munich have received a €200,000 grant to improve big data processing to better understand how gene networks are wired together during development and disease.

Dr. Jana Wolf heads the Mathematical Modeling of Cellular Processes Lab at the MDC. On June 15 she will begin a professorship at FU Berlin . She looks forward to exchanging expertise and ideas with her new colleagues – and to leveraging this knowledge to develop new medical models.

Genome researchers have come together to launch the German COVID-19 OMICS Initiative (DeCOI). DeCOI combines the expertise of more than 22 institutions from across Germany to make a scientific contribution to fighting the COVID-19 pandemic

The coronavirus challenges people around the world every day. Here at the MDC, we are giving our best to help fight the pandemic. Some of our scientists took the time to think about a few of the questions surrounding SARS-CoV-2.

LabHive is one of 1,500 projects born out of the federal government’s #WirVsVirus hackathon. Team leader Dr. Tobias Opialla of the BIMSB/MDC presents the new online platform, which is intended to bundle laboratory capacity and enable more SARS-CoV-2 tests.

The LabHive digital platform aims to provide necessary resources to diagnostic centres to enable more tests for SARS-CoV-2. Tobias Opialla from the Kempa lab is one of 15 volunteers who has been involved in the project since the #WirvsVirus Hackathon organized by the German government.

A new diagnostic test to quickly and easily monitor kidney transplant patients for infection and rejection relies on a simple urine sample and a powerful partner: the gene-editing technology CRISPR. Michael Kaminski, who developed it, leads a new Emmy Noether Group at the BIMSB/MDC & Charité.

In light of the pandemic, the Max Delbrück Center for Molecular Medicine (MDC) is pooling together its resources for projects that advance the understanding of SARS-CoV-2, while scaling down its regular research operations to a minimum.

The group of Matthias Selbach has developed a new online tool that displays the development of the COVID-19 epidemic in Germany clearly and by individual state as well as worldwide.

What goes on inside and between individual cells during the very earliest stages of tumor development? Single cell sequencing technologies and a mouse model have enabled researchers in the labs of Nikolaus Rajewsky and Walter Birchmeier to comprehensively map the cellular diversity of whole salivary gland tumors and trace the path of cancer stem cells.

Research groups from Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC) are joining forces with other Berlin-based partners. Pooling their experience and outstanding expertise in the field of mass spectrometry, they will form a new ‘Forschungskern’ or ‘research core’.

PCAWG, the largest cancer research consortium in the world, has set itself the task of improving our understanding of genetic mutations in tumors. A new study by the international research group, to which the group of Roland Schwarz substantially contributed, is now being published in the journal Nature. 

Single cell technologies for Personalized Medicine – The Berlin Institute of Health (BIH), the Berlin Institute for Medical Systems Biology (BIMSB) of the Max Delbrück Center for Molecular Medicine (MDC) and Charité – Universitätsmedizin Berlin are launching a joint research initiative.

Normally, bird flu viruses do not spread easily from person to person. But if this does happen, it could trigger a pandemic. Researchers from the MDC (Selbach lab) and RKI have now explained in the journal Nature Communications what makes the leap from animals to humans less likely.

An artificial intelligence platform developed by the group of Altuna Akalin in collaboration with Bayer AG can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process. The deeper analysis shows some colorectal subtypes need to be reclassified.

A three-dimensional computer model enables scientists to quickly determine which genes are active in which cells, and their precise location within an organ. A team led by Nikolaus Rajewsky, Berlin, and Nir Friedman, Jerusalem, has published the new method and their insights gained from this in Nature.

Some 27 young researchers have been selected for the prestigious EMBO Young Investigators Programme. Among this year’s awardees is Philipp Junker, a systems biologist at the MDC’s Berlin Institute for Medical Systems Biology.

Researchers at the Max Delbrück Center for Molecular Medicine (MDC) have identified an epigenetic mechanism that appears to strongly influence healthy aging. It’s a protein that controls muscle integrity, lifespan and levels of an essential sugar. How does one protein have that much power?

Modern light microscopic techniques provide extremely detailed insights into organs, but the terabytes of data they produce are usually nearly impossible to process. New software, developed by a team led by MDC scientist Dr. Stephan Preibisch and now presented in Nature Methods, is helping researchers make sense of these reams of data.

LifeTime is one of the six winners of an EU-wide competition in which ambitious and forward-looking research projects are selected and funded. This was officially announced by the European Commission on Tuesday. The coordinators of LifeTime in Berlin and Paris were pleased that they can now begin the actual work. Chancellor Merkel praised the initiative.